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Healthcare-associated infection (HAI) is an infec-
tion which occurs during the patient’s process of care 
in a hospital or other health care facility that is not 
present or incubating at time of admission(19). HAI can 
appear after discharge and results in additional costs 
for health systems, increased resistance of microor-
ganisms to antimicrobials and long term disability(5, 10).
The surgical site infection (SSI) is one of  major 
types of HAI and, although endoscopic gastrostomy is 
not considered a surgery, an adaptation of the Centers 
for Disease Control (CDC) definitions for superficial 
surgical-site infection was been used to detect PEG-
site infections(15, 17).
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ABSTRACT - Context - Healthcare-associated infection represents the most frequent adverse event during care delivery. Medical ad-
vances like percutaneous endoscopic gastrostomy have brought improvement on quality of life to patients but an increased risk of 
healthcare-associated infection. Predictive risk factors for peristomal wound infection are largely unknown but evidence suggests 
that antibiotic prophylaxis and preventive strategies related to infection control may reduce infection rates. Objectives - The primary 
aim was to evaluate the global prevalence rate of peristomal infection. Secondary objectives were to characterise the positive culture 
results, to evaluate the prophylactic antibiotic protocol and to identify potential risk factors for peristomal infection. Methods - Ret-
rospective study of 297 patients with percutaneous endoscopic gastrostomy performed at a general hospital between January 2004 
and September 2010. Patients received prophylactic cefazolin before the endoscopic gastrostomy procedure. Medical records were 
reviewed for demographic data, underling disease conditions to percutaneous endoscopic gastrostomy and patient potential intrinsic 
risk factors. Statistical analysis was made with the statistical program SPSS 17.0. Results - A total of 297 percutaneous endoscopic 
gastrostomy tubes were inserted. Wound infection occurred in 36 patients (12.1%). Staphylococcus aureus methicillin resistant was 
the most frequently isolated microorganism (33.3%) followed by Pseudomonas aeruginosa (30.6%). The incidence rate had been rising 
each year and differ from 4.65% in 2004/2007 to 17.9% in 2008/2010. This finding was consistent with the increasing of prevalence 
global infection rates of the hospital. Most of the infections (55.6%) were detected in the first 10 days post procedure. There was 
no significant difference in age, body mass index values, mean survival time and duration of percutaneous endoscopic gastrostomy 
feeding between patients with and without periostomal infection. Institutional factors, namely global prevalence infection rates and 
the endemic character of Staphylococcus aureus methicillin resistant, play an important role in peristomal infection rates. Traditional 
antibiotic prophylaxis with cefazolin is not adequate due to the prevalence of resistant organisms. Conclusions - Peristomal infection 
is a frequent problem with clinical impact in percutaneous endoscopic gastrostomy patients and should be considered a healthcare 
associated infection. The antimicrobial prophylaxis regimens using cephalosporins are not adequate and need to be reviewed due 
to the high prevalence of Staphylococcus aureus methicillin resistant and other resistant organisms in hospitals and nursing homes.
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Peristomal infection should be considered a health-
care-associated infection, if  it is detected within 30 
days post-discharge, on account of being an invasive 
technique with a medical device that is left in place. 
The post discharge surveillance is essential because 
diagnose confined to the inpatient underestimates the 
rate of infection(8).
Complications of percutaneous endoscopic gas-
trostomy (PEG) have been described in debilitated 
patients(6) and 30-day mortality rates of  4,1%-26% 
have been reported(1). Rodriguez Ortega et al.(17), in 
a Spanish study, found a 30-day-mortality of 8,69%.
Peristomal wound infection occurs in 5% to 39% 
of patients and is the most frequent PEG complica-
tion(13, 21).
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The increasing incidence of resistant organisms in hos-
pitals and long term care facilities justifies, nowadays, the 
clinical impact of these infections(4, 14). In a hospital endemic 
for methicillin-resistant Staphylococcus aureus, MRSA can 
be the most common organism associated with peristomal 
infection(17). In 2011 The Infectious Diseases Society of 
America published the first guidelines for the treatment of 
MRSA infections in hospitals and ambulatory settings, which 
was an important step in the elaboration of new prophylactic 
and therapeutic protocols in health institutions(11).
A cephalosporin-based prophylaxis is usually suggested 
to decrease peristomal infection after PEG insertion(2, 18) but 
these antibiotics are unlikely to be useful in the prevention of 
PEG-site infections caused by MRSA and resistant strains 
of Pseudomonas aeruginosa(9). A recent paper in the British 
Medical Journal (BMJ) suggested the use of co-trimoxazol 
in the PEG prophylaxis(3). This, however, is not a good option 
considering the rate of MRSA in our hospital (47%).
This complication is a public health issue and the use of 
targeted surveillance, with data collected locally, may have 
benefits which can result in improvements in the quality of 
medical care(10).
OBJECTIVES
The primary aim was to evaluate the global prevalence 
rate of  peristomal infection between January 2004 and 
September 2010, and to characterise the microbiological 
characteristics of  positive culture results. The secondary 
objectives were the evaluation of the prophylactic antibiotic 
protocol and study of potential risk factors (age, body mass 
index (BMI) values and length of  time patients use PEG 
tubes) for peristomal infection.
METHODS
Medical records of  adult patients who underwent en-
doscopic gastrostomy at a general hospital between Janua-
ry 2004 and September 2010 were reviewed. After given 
informed consent, patients had the gastrostomy placed by 
pull-method (Kimberly-Clark® or Bard®). An intravenous 
prophylactic cefazolin 1 g was given 1 hour prior to the pro-
cedure. If  patients were under antibiotic therapy for other 
diseases, the cefazolin was not given.
The peristomal infection was defined as a purulent 
discharge with positive wound culture according to CDC 
definitions for superficial surgical site infections. All the 
cultures isolates from peristomal wounds were analysed for 
the antibiogram using the disc diffusion method.
The PEG wound was cared for once every day by sterile 
saline with coverage of dry gauze placed between the external 
fixing device and the skin.
A post-discharge surveillance was performed until the 
patients died or regained oral intake, with multidisciplinary 
follow-up visits at 1, 3, 6, 12 months post PEG.
The statistical analysis of data was made with the statis-
tical software SPSS 17.0 for Windows. The significance level 
was set at 5%. Patients were classified in two groups according 
to the presence of peristomal infection. The comparison of 
the means for age, BMI and duration of PEG use between 
these groups was performed using the T-test for independent 
samples or Man-Whitney U test.
RESULTS
Our study included 297 patients, 210 (70.7%) male and 
87 (29.3%) female. Mean age was 62.06 ± 16.04 years, mean 
BMI was 20,24 ± 4,16 kg/m2 and 37.3% of  patients were 
malnourished (BMI<18.5 kg/m2).
Dysphagia due to neurological disease was the most com-
mon indication with 160 (53.6%) patients. Oropharyngeal 
cancer in 109 (36.7%) patients, other malignant diseases in 
21 (7.1%) patients and esophageal fistula in 7 (2.4%) patients 
were the other underlying diseases for PEG placement.
There was no mortality related to the PEG insertion. The 
mean survival time was 21,36 ± 2,13 months (IC 95%). Ac-
cording to survival analysis using the Kaplan-Meier method 
(Figure 1), the 30th day mortality rate was 12.45%. There was 
no significant difference between the median survival time 
of infected and non infected patients (P>0.05).
Infections were mostly detected in the first 30 days post-pro-
cedure (86.1%) and 55.6% 10 days after PEG insertion.
The overall prevalence of  peristomal infection was 
12.1% (36/297 patients). A total of 41 microorganisms were 
isolated from these 36 patients (Figure 2). Five patients had 
FIGURE 1. Kaplan-Meier survival curve 
FIGURE 2. Prevalence of microorganisms isolated from wound culture 
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two organisms cultured. The PEG wound isolates included 
Staphylococcus aureus in 52.7% (19/36) of  patients, from 
which 12 strains were MRSA (33.3% of global infections); 
Pseudomonas aeruginosa in 30.6% (11/36) patients; Strepto-
coccus ß-haemolyticus in 11.1% (4/36), Klebsiella pneumoniae 
in 2.8% (1/36) and Enterococcus faecallis in 2.8% (1/36).
The incidence rate rose each year, increasing from 4.65% 
in 2004/2007 to 17.9% in 2008/2010 (Figure 3). The increasing 
of peristomal infection rate was consistent with the overall 
prevalence of nosocomial infection rates in our institution 
(Figure 4).
There were no differences between PEG patients with or 
without peristomal infection respecting to age, BMI values 
and duration of PEG feeding (P>0.05).
DISCUSSION
In our study the 30-day mortality rate was 12.5% lower 
then the reported in a large study in United States, in which 
all types of gastrostomy placement were included, the 30-day 
mortality was 23.9% and at 1 year was 63%(1). This may reflect 
a careful selection of patients and the experience of the team.
In previous series the rate of wound infection may differ 
significantly between 5% and 39%(13, 14, 21). In our study, the 
overall peristomal infection rate was 12.1%, an intermediate 
figure, but rising every year and over 25% in 2010. Never-
theless, our overall peristomal infection rate was rising every 
year, reaching 25% in 2010 and a sustained high prevalence 
is expectable for next years.
In this retrospective analysis we were not able to find 
any independent intrinsic patient’s risk factor for peristomal 
infection due to the high prevalence of  co-morbidities in 
this cohort. A prospective randomized study is now being 
conducted in order to evaluate predictive risk factors.
Three important results of our study support the idea that 
peristomal infection must be considered a serious problem 
of healthcare associated infection:
1. the prevalence of peristomal infection has been rising, 
and this parallels the rising of  general nosocomial 
infections in our hospital;
2. most infections (55.6%) were detected in the first 10 days 
after gastrostomy and 86.1% within 30 days post-proce-
dure (86.1%). Globally, the large majority of peristomal 
infection occurred during the hospitalization period or 
shortly after discharge;
3. the microorganisms cultured from PEG wounds 
(MRSA, Pseudomonas aeruginosa, Klebsiella pneumo-
niae, Enterococcus faecallis, for example) reflect the 
nosocomial agents in the hospital.
The high prevalence of multiresistant bacteria was one 
of  the most important findings of  the present study. As 
anticipated by previous reports, multiresistant bacteria, 
namely MRSA, become the dominant pathogens(7, 12, 20). 
Most PEG patients have multiple hospitalization episodes 
prior to the gastrostomy procedure, multiplying the chances 
of becoming colonized by multiresistant organisms. The use 
of broad-spectrum antibiotics before PEG insertion(13) may 
also be an explanation for the high prevalence of Pseudo-
monas aeruginosa (30.6%). Taking into consideration the 
rising of nosocomial infection and multiresistant bacteria, 
namely MRSA, in hospitals worldwide, we believe that in the 
future these agents will become more and more important 
in peristomal infection.
In order to reduce infectious complications, prophylactic 
antibiotics were recommended(18). However, the widespread 
routine of large broad antibiotics might increase the risk of 
emerging resistant organisms. Rao et al.(16) recommended the 
use of a glycopeptide prophylaxis based and a decontamina-
tion protocol before PEG insertion in order to reduce MRSA 
incidence rates in wound infections. Although the MRSA-
colo nization eradication therapy is not a good option due to 
the endemic character of the MRSA in the institution(11), other 
MRSA infection-prevention strategies must be implemented, 
like pre-procedure antiseptic showering with clorhexidine 
and hand hygiene by all clinical staff(15). In our opinion, PEG 
procedure antibiotic prophylaxis should be adapted to the 
prevalence of founded causative organisms. In institutions 
with high prevalence of MRSA, such as our hospital, the use 
of a glycopeptides prophylaxis should be considered.
CONCLUSIONS
In the present study, peristomal infection was a frequent 
and significant problem in PEG patients and should be 
FIGURE 3. Prevalence of peristomal infection after PEG procedure
FIGURE 4. Prevalence of nosocomial infection rates between 2003 and 
2010 (%)
Duarte H, Santos C, Capelas ML, Fonseca J. Peristomal infection after percutaneous endoscopic gastrostomy: a 7-year surveillance of 297 patients
258 Arq Gastroenterol v. 49 - no. 4 - out./dez. 2012 
considered as a healthcare associated infection. We did not 
found any independent risk factor for this infection.
In our recent experience, there was a high prevalence of 
multiresistant bacteria. Looking to the rising prevalence of 
MRSA and other resistant organisms in ours and other hos-
pitals, and also in nursing homes, the classical antimicrobial 
prophylaxis regimens, such as those using cephalosporins, 
are not adequate anymore and need to be critically reviewed.
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antibiótica utilizado e a identificação de potenciais fatores de risco para a infeção peristomal. Método - Estudo retrospetivo em doentes submetidos a 
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afetou 36 doentes (12,1%). O Staphylococcus aureus resistente à metacilina foi o micro-organismo mais frequentemente isolado (33,3%) seguido pela 
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cefazolina não é adequada num contexto de elevada prevalência de micro-organismos resistentes. Conclusões - A infeção peristomal é um problema 
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